Oncology CAR-TCR 2023 – Tim McGuire As the cell therapy world has heated up, so too has the world of cell and gene therapy contract manufacturing.
News Iterum brings first oral penem antibiotic to US market Iterum has launched Orlynvah as a treatment for uncomplicated urinary tract infections (uUTIs), the first oral option in the go-to penem class.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face